Rockwell Medical regains Nasdaq compliance for minimum bid price

Rockwell Medical, Inc. (Nasdaq: RMTI), a hemodialysis products company based in Wixom, Mich., announced it has received notice from Nasdaq that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

According to a press release, the company's shares maintained a closing bid price of at least $1.00 per share from July 1, 2026 to July 15, 2026, satisfying the requirement. Nasdaq has closed the matter as a result.

Rockwell Medical stated it is now in full compliance with all Nasdaq continued listing requirements, and its stock remains listed and traded on the Nasdaq Capital Market under the ticker symbol "RMTI."

You May Also Be Interested In

• LightPath Technologies to sell China unit for $4.5M in installments
• J&J myeloma drug combo cuts disease progression risk by 89% in trial
• Canton Strategic Holdings sells its biotech unit Gravitas Life Sciences